EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan

Hao-Yuan Lee, Chih-Hsien Chuang, Chung-Guei Huang, Tzu-Chun Chuang, Yu-An Kung, Cheng-Hsun Chiu

Biomedical Journal · 2025

DOI: 10.1016/j.bj.2025.100834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Journal, 2025. Verfasst von Hao-Yuan Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan; Molecular Infectious Disease Research Center, Chan…. Hauptthemen laut MEDLINE: COVID-19, Immunization, Secondary, COVID-19 Vaccines, SARS-CoV-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council, Linkou Chang Gung Memorial Hospital, Chang Gung Memorial Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Limited research has explored the immunological effects of a second COVID-19 vaccine booster in older adults within Western Pacific countries. METHODS: This study involved healthcare workers aged ≥65 years who received two doses of ChAdOx1 nCoV-19 (A), mRNA-1273 (M), or MVC-COV1901 (Mc), followed by a booster dose of mRNA-1273. Younger adults served as controls. Humoral and cellular immune responses were measured before and after the vaccination. RESULTS: Younger adults exhibited the highest fold-rise in anti-spike IgG levels (13.20, p < 0.001), followed by the AAMM (9.93, p < 0.001), McMcMM (6.97), and MMMM (4.9, p < 0.05) groups. Cellular response increased most in the McMcMM group (3.77), followed by AAMM (3.04, p < 0.001), MMMM (2.24), and the younger group (1.08). Neutralizing activity against the D614G variant was highest in younger adults (7.77, p < 0.001), followed by AAMM (4.07, p < 0.001), MMMM (2.89, p < 0.05), and McMcMM (2.76). Against the XBB.1.16 variant, titers were significantly lower (17.33-29.08 times less than wild type). The highest fold-rise was observed in the McMcMM group (8.59), followed by AAMM (7.66, p < 0.001), MMMM (4.16), and younger adults (2.26). CONCLUSIONS: A second mRNA COVID-19 booster increased neutralizing antibodies and enhanced T cell responses against SARS-CoV-2 variants. Adapted vaccines targeting new subvariants are critical to strengthen immunity, particularly for older adults facing vaccine-resistant strains.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Immunization, SecondaryCOVID-19 VaccinesSARS-CoV-2Immunogenicity, VaccineHumansAgedMaleFemaleTaiwanAntibodies, Viral2019-nCoV Vaccine mRNA-1273Middle AgedAntibodies, NeutralizingAdultImmunity, CellularImmunoglobulin G

Stichwörter der Autor:innen

COVID-19ImmunogenicityOlder adultSecond booster-dosemRNA vaccine

Substanzen

COVID-19 VaccinesAntibodies, Viral2019-nCoV Vaccine mRNA-1273Antibodies, NeutralizingImmunoglobulin G

Autor:innen und Institutionen

  • Department of Nursing, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Department of Pediatrics, W…
  • Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei, Taiwan; Department of Pediatrics, St. Paul's…
  • Department of Laboratory Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Research Center for Emerging Viral Infections, College of Medicine, Chang Gung University, Taoyuan…
  • Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan; Division of Pediatric Infectious Diseases, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Electronic…

Förderung

  • National Science and Technology Council
  • Linkou Chang Gung Memorial Hospital
  • Chang Gung Memorial Hospital

Zitieren

APA

Lee, H. Y., Chuang, C. H., Huang, C. G., Chuang, T. C., Kung, Y. A., & Chiu, C. H. (2025). Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan. Biomedical Journal. https://doi.org/10.1016/j.bj.2025.100834

Vancouver

Lee HY, Chuang CH, Huang CG, Chuang TC, Kung YA, Chiu CH. Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan. Biomedical Journal. 2025. doi:10.1016/j.bj.2025.100834

BibTeX
@article{Lee2025,
  author = {Lee, Hao-Yuan and Chuang, Chih-Hsien and Huang, Chung-Guei and Chuang, Tzu-Chun and Kung, Yu-An and Chiu, Cheng-Hsun},
  title = {Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan},
  journal = {Biomedical Journal},
  year = {2025},
  doi = {10.1016/j.bj.2025.100834}
}
Kostenlos starten →